EMBC - Embecta Health Trailing Twelve Months Revenue Growth

Brandmark of Embecta Health (EMBC)

Embecta Corp. possesses an impeccable level of patient trust inherited from BD. High-tech plants in Ireland and the US guarantee sterility and stability of product output. The LTM annual sales growth rate demonstrates asset dynamics where the value of -7.80 serves as the baseline indicator. Embecta Corp. dominates the insulin delivery systems segment, leveraging global scale to optimize costs.

Embecta Inc. (EMBC) - Sales Growth YoY (TTM) from 02/11/2024 to 11/15/2026

embecta.com (EMBC) - metric breakdowns and financial figures

- current quotes and average value forecast:
Stock Quotes Embecta Inc.|EMBC - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Embecta Corp.|EMBC - Enterprise Value
- book capitalization data:
Equity per Share Embecta|EMBC - Book Capitalization|Market Capitalization to Book Value embecta.com|EMBC - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Embecta Corp.|EMBC - Long-Term Debt to Capital|Short-Term Debt to Capital Embecta Corp|EMBC - Company Debts|Debt to Book Capitalization Ratio Embecta Inc.|EMBC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Embecta|Immediate Liquidity embecta.com
- earnings and valuation multiples indicators:
EMBC - Company Net Income|Projected Net Profit Embecta Corp.|EMBC - Price to Earnings Ratio|Forward P/E Multiple Embecta Corp.|EMBC - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Embecta Corp|EMBC - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Embecta|EMBC - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months embecta.com|EMBC - Earnings growth in current year|Expected net earnings per share growth next year Embecta Corp.
- sales revenue and business income indicators:
EMBC - Company Revenue|Company Revenue Forecast Embecta Corp.|EMBC - Market Cap to Revenue|Price to Expected Revenue Ratio Embecta Corp.|EMBC - Sales Growth YoY (TTM)
Analysis of all company metrics:Embecta Corp. (EMBC)
Mass-produced product of Embecta Corp.

Steady demand for basic insulin consumables from Embecta Corp. (EMBC) limits opportunities for aggressive pricing, making the analysis of revenue growth rates critically important. By examining the sales dynamics over the last 12 months compared to the same period last year, an investor can track the daily percentage change in rolling annual revenue, allowing for the precise identification of acceleration or deceleration in commercial flows and the timely capture of market trend reversals.

Competitor analysis for Embecta Corp.

Boston Scientific Inc (BSX) - Trailing Twelve Months Revenue Growth|edwards.com - Sales Growth YoY (TTM)|RMD (ResMed Inc.) - Sales Growth YoY (Last 12 Months)|PODD: Sales Growth YoY (TTM)|ZBH - Annual Revenue Growth (Last Twelve Months)|COO (CooperSurgical) - Sales Growth YoY (TTM)|Align Technology Inc (ALGN) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) GMED|Revenue Growth YoY (Last 12 Months) TransMedics Group TMDX|Sales Growth YoY (TTM) ATEC (atecspine.com)|Sales Growth YoY (TTM) CryoLife AORT|ENOV - Sales Growth YoY (Last Twelve Months)|IART: Sales Growth YoY (Last Twelve Months)|ESTA (Establishment Labs) - Revenue Growth YoY (Last 12 Months)|Beta Bionics Inc - Revenue Dynamics YoY (Last Twelve Months)|IRMD (IRADIMED Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Tandem Diabetes Care Inc TNDM|Sales Growth YoY (Last Twelve Months) AxoGen Inc (AXGN)|SI-BONE, Inc. (SIBN) - Revenue Growth Rate YoY (Last Twelve Months)|Orthofix Corp - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) bioventus.com (BVS)|OrthoPediatrics Corp - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) Treace Medical Concepts Inc TMCI|Strata Critical Medical (SRTA) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth CARL (Carlsmed Medical)|Sales Growth YoY (Last Twelve Months) rxsight.com|Revenue Growth YoY (Last 12 Months) ClearPoint Neuro, Inc. (CLPT)|Sales Growth YoY (TTM) STXS|STIM - Trailing Twelve Months Revenue Growth|Sales Growth YoY (Last Twelve Months) Sight Sciences, Inc. SGHT|OBIO: Sales Growth YoY (Last 12 Months)|ANIK: Revenue Growth YoY (Last 12 Months)|InspireMD, Inc. - Revenue Change YoY (Last 12 Months)|zhjmedical.com (ZJYL) - Sales Growth YoY (Last Twelve Months)|VANI (Vivani Medical Inc) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XTNT|Trailing Twelve Months Revenue Growth NeuroOne Medical Technologies NMTC|Sales Growth YoY (TTM) MODD|Revenue Growth YoY (Last 12 Months) myomo.com MYO|Sales Growth YoY (Last Twelve Months) Envoy Medical Inc COCH|Vivos Therapeutics Inc. (VVOS) - Trailing Twelve Months Revenue Growth|envveno.com - Sales Growth YoY (TTM)|SINT (Sintx Technologies Inc) - Sales Growth YoY (Last 12 Months)|TNON (Tenon Medical, Inc.) - Revenue Growth YoY (Last 12 Months)|Lifeward (LFWD) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) autonomix.com|IVF: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) bonebiologics.com (BBLG)|AXNX (Axonics Modulation Technologies) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BIOL (biolase.com)|Annual Revenue Growth (Last Twelve Months) Dynatronics Corp. (DYNT)|Paragon 28 Inc. - Sales Growth YoY (TTM)|invobioscience.com (INVO) - Revenue Growth YoY (Last 12 Months)